1 / 12

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children. L.Chernyshova F.Lapiy National Medical Academy of Postgraduate Education (Kyiv, Ukraine). Background.

ita
Download Presentation

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Evaluationoftheresistanceofbacterialpathogens ofsynopulmonaryinfectionsinchildren L.Chernyshova F.Lapiy National Medical Academy of Postgraduate Education (Kyiv, Ukraine)

  2. Background • Bacterial resistance creates a challenge for clinicians from the viewpoint of correct and successful management of patients. • Antibiotic resistance is an important consideration when treating bacterial infections and there is some evidence that resistance is becoming more widespread.

  3. Background • Etiologic diagnosis is often unreliable; consequently, clinicians must know epidemiology of respiratory infections for optimizing empiric antibiotic therapy.  • In recent years, all major respiratory bacterial pathogens have become more and more resistant to conventional antibiotics.

  4. Background • S.pneumoniae andH.influenzae are the twomost important bacterial causes ofrespiratory infection. • Penicillins andmacrolides are the antibiotics mostcommonly used to treat such infections. • Penicillin-resistant and even multiresistantpneumococci have spread worldwide • Unfortunately, data on antibiotic resistance of S. pneumoniae or Hib in Ukraine are limited

  5. Background • Pneumonia, septicemia, meningitis are considered an important public health problem in Ukraine • Lack of evidence of Hib disease burden in Ukraine has delayed the introduction of vaccines

  6. Background • Hib conjugate vaccination was introduced in Ukraine in 2006. • Mortality from pneumonia, meningitis, septicemia decrease more then 2 time then Hib vaccination was introduced • According to the results of the case-control surveillance of Hib-vaccine effectiveness against pneumonia (sponsored by WHO) was more then 50%.

  7. Background • Vaccination against pneumococcal infections in children has not been introduced in Ukraine • Healthcare providers have little information about pneumococcal infection (burden, resistence) and may not consider the vaccine a priority.

  8. PCV vaccines in Ukraine • PCV7 conjugate vaccine was licensed in Ukraine in 2010 • PCV13 conjugate vaccine under registration

  9. Objective • To investigate the pathogenic bacterial spectrum responsible for respiratory infections and their drug resistance in children.

  10. Our plans • We are beginning research to study the burden of pneumococcal infection among children. • We plan to explore the serotypes of S.pneumoniae, susceptibility to antibiotics, the prevalence of carriage of S.pneumoniae.

  11. Expected benefits • Information on the burden of pneumococcal infection, the prevalence of antibiotic-resistant strains will allow us to rationally use antibiotics in the treatment of respiratory infections and decide on the introduction of vaccination against pneumococcal infection

  12. Welcome to collaboration!

More Related